IL81472A0 - Stabilized formulations of alpha-interferon - Google Patents
Stabilized formulations of alpha-interferonInfo
- Publication number
- IL81472A0 IL81472A0 IL81472A IL8147287A IL81472A0 IL 81472 A0 IL81472 A0 IL 81472A0 IL 81472 A IL81472 A IL 81472A IL 8147287 A IL8147287 A IL 8147287A IL 81472 A0 IL81472 A0 IL 81472A0
- Authority
- IL
- Israel
- Prior art keywords
- active ingredient
- alpha
- interferon
- stabilized formulations
- ifn alpha
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 3
- 238000012270 DNA recombination Methods 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863603444 DE3603444A1 (de) | 1986-02-05 | 1986-02-05 | Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL81472A0 true IL81472A0 (en) | 1987-09-16 |
Family
ID=6293372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL81472A IL81472A0 (en) | 1986-02-05 | 1987-02-04 | Stabilized formulations of alpha-interferon |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0231816B1 (da) |
| JP (1) | JPS62209024A (da) |
| KR (1) | KR870007698A (da) |
| AT (1) | ATE63823T1 (da) |
| AU (1) | AU601712B2 (da) |
| CA (1) | CA1295242C (da) |
| DD (1) | DD284602A5 (da) |
| DE (2) | DE3603444A1 (da) |
| DK (1) | DK164202C (da) |
| ES (1) | ES2028796T3 (da) |
| FI (1) | FI86144C (da) |
| GR (1) | GR3002270T3 (da) |
| HU (1) | HU196560B (da) |
| IE (1) | IE59697B1 (da) |
| IL (1) | IL81472A0 (da) |
| NO (1) | NO169638C (da) |
| NZ (1) | NZ219169A (da) |
| PH (1) | PH24377A (da) |
| PT (1) | PT84243B (da) |
| ZA (1) | ZA87793B (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5275804A (en) * | 1986-02-25 | 1994-01-04 | E. B. Michaels Research Associates, Inc. | Process and composition for oral hygiene |
| US5266310A (en) * | 1987-09-17 | 1993-11-30 | Boehringer Ingelheim International Gmbh | Stabilization of therapeutically active proteins in pharmaceutical preparations |
| DE3731255A1 (de) * | 1987-09-17 | 1989-04-06 | Boehringer Ingelheim Int | Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen |
| DE3803312A1 (de) * | 1988-02-04 | 1989-08-10 | Gerd Prof Dr Med Gross | Verwendung eines interferonenthaltenden gels |
| NZ228285A (en) * | 1988-03-11 | 1991-08-27 | Teikoku Seiyaku Kk | Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration |
| DE68917883T2 (de) * | 1988-05-06 | 1995-02-23 | Toray Industries | Stabile interferon-beta-zusammensetzung. |
| US5389676A (en) * | 1991-03-22 | 1995-02-14 | E. B. Michaels Research Associates, Inc. | Viscous surfactant emulsion compositions |
| US5244652A (en) * | 1991-03-22 | 1993-09-14 | E. B. Michaels Research Associates, Inc. | Viscous surface active composition |
| WO1993006856A1 (en) * | 1991-10-11 | 1993-04-15 | Mark Cedric Gillies | Treating ophthalmic fibrosis using interferon-alpha |
| US5863530A (en) * | 1991-10-11 | 1999-01-26 | Spruson & Ferguson | Treating ophthalmic fibrosis using interferon-α |
| US6630168B1 (en) * | 1997-02-20 | 2003-10-07 | Biomedicines, Inc. | Gel delivery vehicles for anticellular proliferative agents |
| FI106465B (fi) * | 1998-06-10 | 2001-02-15 | Suomen Punainen Risti Veripalv | Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi |
| US6923966B2 (en) | 1999-04-08 | 2005-08-02 | Schering Corporation | Melanoma therapy |
| JP4536194B2 (ja) * | 2000-02-17 | 2010-09-01 | 大日本住友製薬株式会社 | 安定な注射用製剤 |
| WO2001066084A2 (en) * | 2000-03-07 | 2001-09-13 | Rush-Presbyterian-St. Luke's Medical Center | Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| US6328987B1 (en) * | 2000-11-03 | 2001-12-11 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions containing alpha interferon |
| CA2464889A1 (en) * | 2001-11-02 | 2003-05-08 | Sekisui Chemical Co., Ltd. | Cytokine-inducing material and cytokine-inducing instrument |
| US8137677B2 (en) * | 2005-10-06 | 2012-03-20 | Allergan, Inc. | Non-protein stabilized clostridial toxin pharmaceutical compositions |
| JP5740653B2 (ja) * | 2009-05-29 | 2015-06-24 | イノニクス テクノロジーズ インコーポレーティッドＩｎｎｏｎｉｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ， Ｉｎｃｏｒｐｏｒａｔｅｄ | ヒト病原体の感染を低減する際に使用する組成物 |
| RU2431489C1 (ru) * | 2010-05-25 | 2011-10-20 | Федеральное государственное учреждение "Российский научный центр рентгенорадиологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "РНЦРР Росмедтехнологий") | Способ лечения хронических воспалительных заболеваний толстого кишечника |
| DK2819682T3 (da) * | 2012-03-01 | 2017-08-21 | Firststring Res Inc | Topikale geler indeholdende alpha-connexin c-terminal (act) -peptider |
| JP6081156B2 (ja) * | 2012-11-15 | 2017-02-15 | アルケア株式会社 | ハイドロゲル |
| DE102012222365A1 (de) | 2012-12-05 | 2014-06-05 | Aesculap Ag | Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen |
| US20160120946A1 (en) * | 2013-06-09 | 2016-05-05 | Efranat Ltd. | Compositions comprising gc-macrophage activating factor and uses thereof |
| CN110167516B (zh) | 2017-01-31 | 2022-08-30 | 金伯利-克拉克环球有限公司 | 包含苯甲酸酯的抗细菌组合物及利用该组合物抑制细菌生长的方法 |
| MX2023004631A (es) | 2020-10-22 | 2023-07-20 | Xequel Bio Inc | Formulaciones peptidicas y usos oftalmicos de las mismas. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1234383A (en) * | 1982-03-17 | 1983-09-22 | Inter-Yeda Ltd. | Interferon stabilised with polyvinyl-pyrrolidone |
| JPS6061535A (ja) * | 1983-08-24 | 1985-04-09 | エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト | 製薬学的組成物 |
| JPS6069037A (ja) * | 1983-09-26 | 1985-04-19 | Sunstar Inc | エリテマト−デス治療用外用剤 |
| EP0139286B1 (en) * | 1983-10-14 | 1991-08-21 | Sumitomo Pharmaceuticals Company, Limited | Prolonged sustained-release preparations |
| US4680175A (en) * | 1984-02-07 | 1987-07-14 | Interferon Sciences, Inc. | Interferon administration vehicles |
| CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
| JPS60228422A (ja) * | 1984-04-26 | 1985-11-13 | Suntory Ltd | 安定化された生理活性物質製剤 |
| JPS60260523A (ja) * | 1984-06-07 | 1985-12-23 | Asahi Chem Ind Co Ltd | インタ−フエロンの凍結乾燥医薬組成物 |
-
1986
- 1986-02-05 DE DE19863603444 patent/DE3603444A1/de not_active Withdrawn
-
1987
- 1987-01-21 DE DE8787100792T patent/DE3770280D1/de not_active Expired - Lifetime
- 1987-01-21 AT AT87100792T patent/ATE63823T1/de not_active IP Right Cessation
- 1987-01-21 ES ES198787100792T patent/ES2028796T3/es not_active Expired - Lifetime
- 1987-01-21 EP EP87100792A patent/EP0231816B1/de not_active Expired - Lifetime
- 1987-02-03 FI FI870457A patent/FI86144C/fi not_active IP Right Cessation
- 1987-02-03 CA CA000528832A patent/CA1295242C/en not_active Expired - Lifetime
- 1987-02-03 DD DD87299676A patent/DD284602A5/de not_active IP Right Cessation
- 1987-02-04 IL IL81472A patent/IL81472A0/xx not_active IP Right Cessation
- 1987-02-04 PT PT84243A patent/PT84243B/pt not_active IP Right Cessation
- 1987-02-04 AU AU68292/87A patent/AU601712B2/en not_active Ceased
- 1987-02-04 IE IE29587A patent/IE59697B1/en not_active IP Right Cessation
- 1987-02-04 HU HU87385A patent/HU196560B/hu not_active IP Right Cessation
- 1987-02-04 JP JP62024423A patent/JPS62209024A/ja active Pending
- 1987-02-04 DK DK058387A patent/DK164202C/da not_active IP Right Cessation
- 1987-02-04 NZ NZ219169A patent/NZ219169A/en unknown
- 1987-02-04 NO NO870441A patent/NO169638C/no unknown
- 1987-02-04 ZA ZA87793A patent/ZA87793B/xx unknown
- 1987-02-05 KR KR870000912A patent/KR870007698A/ko not_active Ceased
- 1987-02-05 PH PH34815A patent/PH24377A/en unknown
-
1991
- 1991-07-08 GR GR91400966T patent/GR3002270T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0231816B1 (de) | 1991-05-29 |
| NO870441D0 (no) | 1987-02-04 |
| EP0231816A3 (en) | 1987-09-23 |
| DK164202B (da) | 1992-05-25 |
| ZA87793B (en) | 1988-10-26 |
| IE870295L (en) | 1987-08-05 |
| AU601712B2 (en) | 1990-09-20 |
| IE59697B1 (en) | 1994-03-23 |
| GR3002270T3 (en) | 1992-12-30 |
| FI870457L (fi) | 1987-08-06 |
| DE3603444A1 (de) | 1987-08-06 |
| NZ219169A (en) | 1990-04-26 |
| PH24377A (en) | 1990-06-13 |
| DK58387A (da) | 1987-08-06 |
| NO870441L (no) | 1987-08-06 |
| AU6829287A (en) | 1987-08-06 |
| DK58387D0 (da) | 1987-02-04 |
| FI86144B (fi) | 1992-04-15 |
| DD284602A5 (de) | 1990-11-21 |
| HU196560B (en) | 1988-12-28 |
| HUT43494A (en) | 1987-11-30 |
| KR870007698A (ko) | 1987-09-21 |
| CA1295242C (en) | 1992-02-04 |
| EP0231816A2 (de) | 1987-08-12 |
| PT84243A (de) | 1987-03-01 |
| ATE63823T1 (de) | 1991-06-15 |
| DK164202C (da) | 1992-10-19 |
| ES2028796T3 (es) | 1992-07-16 |
| FI870457A0 (fi) | 1987-02-03 |
| PT84243B (pt) | 1989-09-14 |
| NO169638C (no) | 1992-07-22 |
| FI86144C (fi) | 1992-07-27 |
| JPS62209024A (ja) | 1987-09-14 |
| DE3770280D1 (de) | 1991-07-04 |
| NO169638B (no) | 1992-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL81472A0 (en) | Stabilized formulations of alpha-interferon | |
| DK203787A (da) | Praeparat til nasal administrering | |
| IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
| ES2009216A6 (es) | Metodo de preparar un derivado de interleucina-lalfa. | |
| IL68456A0 (en) | Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles | |
| IL79816A0 (en) | Pharmaceutical composition comprising a drug-polymer matrix | |
| AU1518492A (en) | Pharmaceutical compositions for transcutaneous administration | |
| DK305087A (da) | Buprenorphinholdigt farmaceutisk suppositorium | |
| IL78604A (en) | Process for the preparation of homogeneous,pure alpha-interferon,alpha-interferon produced thereby and pharmaceutical compositions containing it | |
| GB2021409A (en) | Pharmaceutical composition | |
| IE56229B1 (en) | 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them | |
| DK0524696T3 (da) | Orale præparater indeholdende dapiprazol | |
| IL106289A0 (en) | Phospholipid derivatives, their preparation and pharmaceutical compositions containing them | |
| MY104088A (en) | Peptide-drugs compositions containing (alpha)-aminoboroic acid derivatives. | |
| IT1223132B (it) | Composizione farmaceutica per somministrazione nasale | |
| EP0355899A3 (en) | Nucleotide derivatives | |
| ES2091571T3 (es) | Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| IT8819541A0 (it) | Composizione farmaceutica per somministrazione nasale. | |
| IT1241459B (it) | Composizioni farmaceutiche per la somministrazione rettale di calcitonina | |
| IL81926A0 (en) | Pharmaceutical compositions for the oral administration of active proteins | |
| IT8448979A1 (it) | Uso dell'acido ialuronico come veicolo per farmaci oftalmici e composizioni farmaceutiche contenenti questa sostanza. | |
| IT8723007A0 (it) | Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle | |
| IT8519017A0 (it) | Composto con attivita'antiallergica, procedimento per lasua preparazione e relative composizioni farmaceutiche. | |
| IT8520150A0 (it) | Nuovi derivati ad attivita'terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |